Streamline Health Solutions, Inc.
STRM · NASDAQ
4/30/2025 | 1/31/2025 | 10/31/2024 | 7/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.08 | 0.16 | 0.07 | -0.01 |
| FCF Yield | -9.83% | 5.06% | -22.11% | 0.40% |
| EV / EBITDA | -412.50 | -89.58 | -30.40 | -35.13 |
| Quality | ||||
| ROIC | -4.38% | -6.18% | -7.51% | -7.77% |
| Gross Margin | 53.85% | 46.07% | 46.03% | 46.87% |
| Cash Conversion Ratio | 0.59 | -0.52 | 0.71 | -0.11 |
| Growth | ||||
| Revenue 3-Year CAGR | -8.87% | -10.41% | -8.41% | -4.74% |
| Free Cash Flow Growth | -228.72% | 146.67% | -1,699.20% | 108.74% |
| Safety | ||||
| Net Debt / EBITDA | -208.85 | -33.36 | -17.02 | -7.85 |
| Interest Coverage | -2.03 | -2.85 | -3.99 | -4.47 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 27.49 | 5.74 | 22.18 | 16.70 |